10-30626134-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_183058.3(LYZL2):āc.269A>Gā(p.Glu90Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000164 in 1,461,852 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_183058.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LYZL2 | NM_183058.3 | c.269A>G | p.Glu90Gly | missense_variant | 3/5 | ENST00000647634.2 | NP_898881.3 | |
LYZL2 | XM_011519306.3 | c.407A>G | p.Glu136Gly | missense_variant | 3/4 | XP_011517608.1 | ||
LYZL2 | XM_011519307.3 | c.407A>G | p.Glu136Gly | missense_variant | 3/4 | XP_011517609.1 | ||
LYZL2 | XR_930469.3 | n.455A>G | non_coding_transcript_exon_variant | 3/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LYZL2 | ENST00000647634.2 | c.269A>G | p.Glu90Gly | missense_variant | 3/5 | NM_183058.3 | ENSP00000497408.1 | |||
LYZL2 | ENST00000375318.4 | c.407A>G | p.Glu136Gly | missense_variant | 3/5 | 1 | ENSP00000364467.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000836 AC: 21AN: 251120Hom.: 0 AF XY: 0.0000442 AC XY: 6AN XY: 135692
GnomAD4 exome AF: 0.0000164 AC: 24AN: 1461852Hom.: 0 Cov.: 31 AF XY: 0.0000110 AC XY: 8AN XY: 727228
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 06, 2021 | The c.407A>G (p.E136G) alteration is located in exon 3 (coding exon 3) of the LYZL2 gene. This alteration results from a A to G substitution at nucleotide position 407, causing the glutamic acid (E) at amino acid position 136 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at